We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
HDFC Bank
HDB
$119B
| $13.2M | 0.17% |
+897,824
| New | +$13.1M |
|
152
McKesson
MCK
$98.5B
| $13.2M | 0.17% |
58,438
+16,901
| +41% | +$3.75M |
|
153
RenaissanceRe
RNR
$13.7B
| $13.2M | 0.17% |
132,503
+67,026
| +102% | +$6.7M |
|
154
CF Industries
CF
$19.2B
| $13.1M | 0.17% |
230,725
+208,390
| +933% | +$12.4M |
|
|
FOLD
155
DELISTED
Amicus Therapeutics
FOLD
| $13M | 0.17% |
1,195,514
-73,715
| -6% | -$650K |
|
|
HBI
156
DELISTED
Hanesbrands
HBI
| $12.9M | 0.17% |
+385,631
| New | +$11.7M |
|
157
Intercontinental Exchange
ICE
$82.4B
| $12.8M | 0.17% |
273,990
+215,580
| +369% | +$9.72M |
|
158
Element Solutions
ESI
$9.12B
| $12.8M | 0.17% |
497,584
-625,424
| -56% | -$15M |
|
159
Signet Jewelers
SIG
$3.55B
| $12.7M | 0.17% |
91,267
+86,005
| +1,634% | +$10.7M |
|
160
Camden Property Trust
CPT
$11.3B
| $12.7M | 0.16% |
+161,943
| New | +$12.4M |
|
|
BLUE
161
DELISTED
bluebird bio
BLUE
| $12.5M | 0.16% |
8,004
-644
| -7% | -$850K |
|
162
United Therapeutics
UTHR
$26.3B
| $12.5M | 0.16% |
72,584
-199,381
| -73% | -$30.4M |
|
|
RAX
163
DELISTED
Rackspace Hosting Inc
RAX
| $12.4M | 0.16% |
+239,688
| New | +$11.8M |
|
164
Banco Bradesco
BBD
$38.1B
| $12.3M | 0.16% |
2,824,418
+1,024,720
| +57% | +$5.03M |
|
165
DuPont de Nemours
DD
$18.6B
| $12.2M | 0.16% |
+100,461
| New | +$11.9M |
|
166
Starbucks
SBUX
$118B
| $12.1M | 0.16% |
+255,860
| New | +$11.5M |
|
167
Southwest Airlines
LUV
$22.1B
| $12M | 0.16% |
270,752
-467,088
| -63% | -$20.4M |
|
168
Dick's Sporting Goods
DKS
$18.4B
| $11.9M | 0.15% |
+208,447
| New | +$11.4M |
|
|
MDCO
169
DELISTED
Medicines Co
MDCO
| $11.8M | 0.15% |
420,096
+373,870
| +809% | +$10.5M |
|
170
Spire
SR
$4.92B
| $11.7M | 0.15% |
229,158
-2,127
| -0.9% | -$112K |
|
|
TDAY
171
USA Today Co
TDAY
$1.23B
| $11.7M | 0.15% |
+488,879
| New | +$11.3M |
|
172
Honeywell
HON
$77.1B
| $11.7M | 0.15% |
+124,796
| New | +$11.4M |
|
|
XEC
173
DELISTED
CIMAREX ENERGY CO
XEC
| $11.7M | 0.15% |
101,622
+98,410
| +3,064% | +$10.6M |
|
|
LLL
174
DELISTED
L3 Technologies, Inc.
LLL
| $11.6M | 0.15% |
+92,117
| New | +$11.7M |
|
175
Madison Square Garden
MSGS
$9.54B
| $11.6M | 0.15% |
+191,618
| New | +$10.5M |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.